Michał Andrzej Kozicz
Research Subjects
Michał Andrzej Kozicz has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Adriana Wojciechowska
The Medical University of Lublin, Aleje Racławickie 1, 20-059 Lublin, Poland
10 shared publications - Aleksandra Mazurkiewicz
Ludwik Rydygier Specialist Hospital in Kraków, Złotej Jesieni 1 Estate, 31-826 Kraków, Poland
10 shared publications - Joanna Męczyńska
St. John Paul II Mazovian Provincial Hospital in Siedlce, Poland, Księcia Józefa Poniatowskiego 26, 08-110 Siedlce, Poland
10 shared publications - Justyna Marcicka
Ludwik Rydygier Specialist Hospital in Kraków, Złotej Jesieni 1 Estate, 31-826 Kraków, Poland
10 shared publications - Magdalena Kołodziej
Brothers Hospitallers Hospital in Kraków, Trynitarska 11, 31-061 Kraków, Poland
10 shared publications - Nazarii Saiuk
Ludwik Rydygier Specialist Hospital in Kraków, Złotej Jesieni 1 Estate, 31-826 Kraków, Poland
10 shared publications
Latest Publications
- Open Access
- 13 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 53437
Exploring the Therapeutic Potential of Nicotinamide Mononucleotide: A Review of Safety and Efficacy with Emphasis on Diabetes
Introduction: Nicotinamide mononucleotide (NMN) is a supplement that can boost nicotinamide adenine dinucleotide (NAD+) levels in the body, which is crucial for maintaining energy balance and stress response. Declining NAD+ levels with age contribute to aging and related diseases, making NMN supplementation a potential solution. Despite its potential benefits, NMN’s safety and efficacy need further investigation. Aim of the Study: This study aimed to analyze recent research on NMN supplementation regarding its safety and efficacy in improving human health, especially in patients with diabetes and prediabetes, and to suggest potential research directions for this compound. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, focusing on literature from the past 5 years, primarily on randomized controlled trials. The databases were searched using the term “nicotinamide mononucleotide” to gather articles, and references from selected articles were included. Conclusion: A beneficial direction for NMN research is an in-depth analysis of its effects on skeletal muscles in both healthy individuals and those with diabetes. Studies on larger groups, with higher doses, and over longer periods are crucial to determine the optimal supplementation protocol and assess individual variability in NMN’s metabolic effects.
- 13 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 53437
Open AccessExploring the Therapeutic Potential of Nicotinamide Mononucleotide: A Review of Safety and Efficacy with Emphasis on Diabetes
Introduction: Nicotinamide mononucleotide (NMN) is a supplement that can boost nicotinamide adenine dinucleotide (NAD+) levels in the body, which is crucial for maintaining energy balance and stress response. Declining NAD+ levels with age contribute to aging and related diseases, making NMN supplementation a potential solution. Despite its potential benefits, NMN’s safety and efficacy need further investigation. Aim of the Study: This study aimed to analyze recent research on NMN supplementation regarding its safety and efficacy in improving human health, especially in patients with diabetes and prediabetes, and to suggest potential research directions for this compound. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, focusing on literature from the past 5 years, primarily on randomized controlled trials. The databases were searched using the term “nicotinamide mononucleotide” to gather articles, and references from selected articles were included. Conclusion: A beneficial direction for NMN research is an in-depth analysis of its effects on skeletal muscles in both healthy individuals and those with diabetes. Studies on larger groups, with higher doses, and over longer periods are crucial to determine the optimal supplementation protocol and assess individual variability in NMN’s metabolic effects.
- Open Access
- 28 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 53183
Complex minoxidil and platelet-rich plasma therapy effectiveness and its impact on physical performance
Background Minoxidil and platelet-rich plasma (PRP) are proven treatments for androgenetic alopecia, however their combined therapy is not as researched. Research materials and methods Materials used for our research consist of published papers that pertain to both minoxidil and platelet-rich plasma therapies. More comprehensive papers, such as those including other substances were also included although results about other substances were not included, we simply discarded them. Each of the found and chosen articles were added and processed by various formulas which aim were to calculate efficacy of combined therapy while minimizing the errors and biases that could prop up in the source papers. Overall goal was to consolidate knowledge of the efficacy of combined therapy of minoxidil and platelet-rich plasma with emphasis on effect that could affect the physical performance. Results All trials have shown statistically significant improvement when compared to minoxidil monotherapy. Compared to PRP monotherapy results had been superior although not always in statistically significant manner. No trials have shown additional, adverse interactions, side effects or impacts on physical performance beyond those expected from the monotherapies, proving combined is as safe as monotherapies. Conclusion Combined therapy is proven to yield better results, while remaining a safe and cost-effective method. It doesn’t impact physical performance in any way if taken correctly. Still higher quantity of research is welcome to make those finding more stable and in order to better assess the positive effect of combing titular substances.
- 28 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 19, 53183
Open AccessComplex minoxidil and platelet-rich plasma therapy effectiveness and its impact on physical performance
Background Minoxidil and platelet-rich plasma (PRP) are proven treatments for androgenetic alopecia, however their combined therapy is not as researched. Research materials and methods Materials used for our research consist of published papers that pertain to both minoxidil and platelet-rich plasma therapies. More comprehensive papers, such as those including other substances were also included although results about other substances were not included, we simply discarded them. Each of the found and chosen articles were added and processed by various formulas which aim were to calculate efficacy of combined therapy while minimizing the errors and biases that could prop up in the source papers. Overall goal was to consolidate knowledge of the efficacy of combined therapy of minoxidil and platelet-rich plasma with emphasis on effect that could affect the physical performance. Results All trials have shown statistically significant improvement when compared to minoxidil monotherapy. Compared to PRP monotherapy results had been superior although not always in statistically significant manner. No trials have shown additional, adverse interactions, side effects or impacts on physical performance beyond those expected from the monotherapies, proving combined is as safe as monotherapies. Conclusion Combined therapy is proven to yield better results, while remaining a safe and cost-effective method. It doesn’t impact physical performance in any way if taken correctly. Still higher quantity of research is welcome to make those finding more stable and in order to better assess the positive effect of combing titular substances.
- Open Access
- 18 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 52875
Impact of Fasting and Dietary Interventions on the Development and Treatment of Non-Hodgkin’s Lymphomas and Other Cancers - a review
Introduction: The present study investigated the role of fasting and diet in the development and treatment of cancers, with a focus on non-Hodgkin’s lymphomas. Dietary components and regimens have an impact on the risk of development of malignances as well as on the treatment of the disease. Cancerous subtypes react differently to various dietary compounds and regimes. Although not widely used- fasting can be valuable help in cancer treatment. In this article we show how diet modifications and restrictions can affect existing therapies. Aim of the study: By analyzing current literature, the study aimed to understand how various dietary components and regimens influence cancer risk and treatment efficacy. Methods: Extensive research was conducted using PubMed and Google Scholar. References from selected articles were included in the analysis. Results: Consuming high amount of fruits and vegetables, unsaturated fats and supplementing vitamin D can reduce the risk of malignancies, with red meat, dairy products and saturated fats intake increasing it. Fasting affects lipid, glucose, protein and neuroendocrine metabolism in the way that helps the treatment of cancers. It slows down tumor growth, reduces some symptoms and improves the effects of chemotherapy. Exploring this topic further could propagate suitable diets for cancer subtypes as well as popularize fasting, which is not yet a widely known adition to standard anti-cancer treatments.
- 18 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 52875
Open AccessImpact of Fasting and Dietary Interventions on the Development and Treatment of Non-Hodgkin’s Lymphomas and Other Cancers - a review
Introduction: The present study investigated the role of fasting and diet in the development and treatment of cancers, with a focus on non-Hodgkin’s lymphomas. Dietary components and regimens have an impact on the risk of development of malignances as well as on the treatment of the disease. Cancerous subtypes react differently to various dietary compounds and regimes. Although not widely used- fasting can be valuable help in cancer treatment. In this article we show how diet modifications and restrictions can affect existing therapies. Aim of the study: By analyzing current literature, the study aimed to understand how various dietary components and regimens influence cancer risk and treatment efficacy. Methods: Extensive research was conducted using PubMed and Google Scholar. References from selected articles were included in the analysis. Results: Consuming high amount of fruits and vegetables, unsaturated fats and supplementing vitamin D can reduce the risk of malignancies, with red meat, dairy products and saturated fats intake increasing it. Fasting affects lipid, glucose, protein and neuroendocrine metabolism in the way that helps the treatment of cancers. It slows down tumor growth, reduces some symptoms and improves the effects of chemotherapy. Exploring this topic further could propagate suitable diets for cancer subtypes as well as popularize fasting, which is not yet a widely known adition to standard anti-cancer treatments.
- Open Access
- 18 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 52948
The treatment of hyperphagia and obesity in Prader-Willi Syndrome
Introduction: Prader-Willi Syndrome (PWS) is a genetic neurodevelopmental disorder, in which the central clinical characteristics are hyperphagia and obesity. Obesity leads to higher mortality rates in PWS patients and thus, effective and safe treatment of hyperphagia and obesity in PWS individuals is an important aspect of PWS therapy. Aim of the study: The aim of the study was to research both the new and the more standard treatment options of hyperphagia and obesity in PWS patients. Methods and Materials: An extensive literature search was conducted using PubMed database. Only articles from the past 5 years were taken into consideration. The keywords used during the search were: prader willi syndrome, obesity, treatment. Results: Our research showed that in the treatment of hyperphagia and obesity in PWS patients, health professionals may consider the use of pharmacological treatment options, surgery and neuromodulatory options. Moreover, physical activity and environmental control are beneficial in limiting caloric intake and improving body mass index. Furthermore, early diagnosis and thus starting treatment in early childhood are beneficial in preventing the progression of obesity. However, more research is needed to determine which treatment options are best suited for specific patients.
- 18 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 52948
Open AccessThe treatment of hyperphagia and obesity in Prader-Willi Syndrome
Introduction: Prader-Willi Syndrome (PWS) is a genetic neurodevelopmental disorder, in which the central clinical characteristics are hyperphagia and obesity. Obesity leads to higher mortality rates in PWS patients and thus, effective and safe treatment of hyperphagia and obesity in PWS individuals is an important aspect of PWS therapy. Aim of the study: The aim of the study was to research both the new and the more standard treatment options of hyperphagia and obesity in PWS patients. Methods and Materials: An extensive literature search was conducted using PubMed database. Only articles from the past 5 years were taken into consideration. The keywords used during the search were: prader willi syndrome, obesity, treatment. Results: Our research showed that in the treatment of hyperphagia and obesity in PWS patients, health professionals may consider the use of pharmacological treatment options, surgery and neuromodulatory options. Moreover, physical activity and environmental control are beneficial in limiting caloric intake and improving body mass index. Furthermore, early diagnosis and thus starting treatment in early childhood are beneficial in preventing the progression of obesity. However, more research is needed to determine which treatment options are best suited for specific patients.
- Open Access
- 16 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52874
Can vitamin supplementation improve quality of life and disease severity in patients with rheumatoid arthritis, or is physical activity enough?
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and progressive joint destruction, significantly impacting quality of life. While conventional treatments focus on managing symptoms and slowing disease progression through pharmacological means, the potential role of complementary therapies like vitamin supplementation or increased physical activity has garnered increasing interest. Aim of the Study: This narrative review explores the existing literature on the efficacy and mechanisms of various vitamins in the management of RA. By synthesizing current research findings, we aim to provide a comprehensive overview of how vitamin supplementation might influence RA outcomes, offering insights into potential integrative approaches to enhance patient care. Methods and Materials: A thorough search was conducted using PubMed and Google Scholar, focusing on literature published in the past five years. Vitamins with potential impacts on RA progression were identified and paired with the term "Rheumatoid Arthritis" to collect data on their influence on the disease's incidence and management, as well as the mechanisms involved. Additionally, references from selected articles were reviewed and included in the analysis. This method ensured a comprehensive evaluation of the current evidence regarding vitamin supplementation in RA treatment. Similarly, studies on the impact of physical activity on RA were also reviewed. Results: The influence of physical activity on serum inflammatory markers in RA patients was limited. Vitamin D supplementation significantly reduced disease activity, alleviated pain, and mitigated methotrexate-related side effects, especially in patients with baseline vitamin D deficiency or lower serum levels. In contrast, other vitamins have not exhibited the same positive effects. These findings underscore the need for continued research to optimize the role of various vitamins in managing RA effectively.
- 16 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52874
Open AccessCan vitamin supplementation improve quality of life and disease severity in patients with rheumatoid arthritis, or is physical activity enough?
Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and progressive joint destruction, significantly impacting quality of life. While conventional treatments focus on managing symptoms and slowing disease progression through pharmacological means, the potential role of complementary therapies like vitamin supplementation or increased physical activity has garnered increasing interest. Aim of the Study: This narrative review explores the existing literature on the efficacy and mechanisms of various vitamins in the management of RA. By synthesizing current research findings, we aim to provide a comprehensive overview of how vitamin supplementation might influence RA outcomes, offering insights into potential integrative approaches to enhance patient care. Methods and Materials: A thorough search was conducted using PubMed and Google Scholar, focusing on literature published in the past five years. Vitamins with potential impacts on RA progression were identified and paired with the term "Rheumatoid Arthritis" to collect data on their influence on the disease's incidence and management, as well as the mechanisms involved. Additionally, references from selected articles were reviewed and included in the analysis. This method ensured a comprehensive evaluation of the current evidence regarding vitamin supplementation in RA treatment. Similarly, studies on the impact of physical activity on RA were also reviewed. Results: The influence of physical activity on serum inflammatory markers in RA patients was limited. Vitamin D supplementation significantly reduced disease activity, alleviated pain, and mitigated methotrexate-related side effects, especially in patients with baseline vitamin D deficiency or lower serum levels. In contrast, other vitamins have not exhibited the same positive effects. These findings underscore the need for continued research to optimize the role of various vitamins in managing RA effectively.
- Open Access
- 16 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52893
Efficacy and Safety of Miebo® (Perfluorohexyloctane Ophthalmic Solution) in Treating Dry Eye Disease - a narrative review
Introduction: Dry eye disease (DED) is a prevalent and debilitating ocular condition characterized by discomfort, visual disturbances, and tear film instability. Recent therapeutic developments have introduced perfluorohexyloctane ophthalmic solution (Miebo®) as a potential treatment for DED, particularly in patients with meibomian gland dysfunction (MGD). Aim of the Study: This narrative review aims to evaluate the efficacy and safety of Miebo® in treating DED based on current clinical evidence. Materials and Methods: A comprehensive literature search was conducted in PubMed, Embase, and Cochrane Library databases up to May 2024 resulting in the identification of 9 studies. The review included randomized controlled trials, prospective cohort studies, and systematic reviews that focused on the use of Miebo® for DED. Data on efficacy in improving tear film stability and symptom relief, as well as safety profiles, were extracted and analyzed. Results: The evidence indicates that Miebo® significantly enhances tear film stability and alleviates symptoms of DED, with pronounced benefits observed in patients with MGD. Comparative studies demonstrate that Miebo® is more effective than conventional treatments, such as artificial tears and lipid-based formulations. Safety assessments reveal minimal ocular surface discomfort and no significant systemic adverse events associated with Miebo® use. Conclusion: Miebo® shows substantial efficacy and a favorable safety profile in managing DED, making it a valuable therapeutic option, particularly for patients who do not respond to traditional therapies. However, further research is needed to confirm its long-term effectiveness and safety.
- 16 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52893
Open AccessEfficacy and Safety of Miebo® (Perfluorohexyloctane Ophthalmic Solution) in Treating Dry Eye Disease - a narrative review
Introduction: Dry eye disease (DED) is a prevalent and debilitating ocular condition characterized by discomfort, visual disturbances, and tear film instability. Recent therapeutic developments have introduced perfluorohexyloctane ophthalmic solution (Miebo®) as a potential treatment for DED, particularly in patients with meibomian gland dysfunction (MGD). Aim of the Study: This narrative review aims to evaluate the efficacy and safety of Miebo® in treating DED based on current clinical evidence. Materials and Methods: A comprehensive literature search was conducted in PubMed, Embase, and Cochrane Library databases up to May 2024 resulting in the identification of 9 studies. The review included randomized controlled trials, prospective cohort studies, and systematic reviews that focused on the use of Miebo® for DED. Data on efficacy in improving tear film stability and symptom relief, as well as safety profiles, were extracted and analyzed. Results: The evidence indicates that Miebo® significantly enhances tear film stability and alleviates symptoms of DED, with pronounced benefits observed in patients with MGD. Comparative studies demonstrate that Miebo® is more effective than conventional treatments, such as artificial tears and lipid-based formulations. Safety assessments reveal minimal ocular surface discomfort and no significant systemic adverse events associated with Miebo® use. Conclusion: Miebo® shows substantial efficacy and a favorable safety profile in managing DED, making it a valuable therapeutic option, particularly for patients who do not respond to traditional therapies. However, further research is needed to confirm its long-term effectiveness and safety.
- Open Access
- 10 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52810
influence of the Dark Triad on various aspects of life – a review
Introduction: The Dark Triad is a construct devised by Paulhus and Williams in 2002. It comprises of three personality disorders: Narcissism, Machiavellianism and psychopathy, that are believed to be debilitating both to people exhibiting these traits and their social environment. Aim of the Study: The aim of the study was to collect and analyse current literature regarding the Dark Triad and the influence of its components on different areas of functioning. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, with the primary focus on literature from the past 5 years. These databases were searched using “the Dark Triad” and its components names as entries to gather articles. Additionally, references from selected articles were included in the analysis. Results: Our article showed that the components of the Dark Triad influence many areas of functioning, although this influence is not always negative. Having all the traits of the Dark Triad is more likely to induce immoral behaviour than having the individual traits in isolation. Thus, further research of the Dark Triad is needed, especially regarding different facets of its components. Devising more in-depth questionnaires that would cover all sub-divisions of the Dark Triad components would largely bolster the research in this field.
- 10 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 16, 52810
Open Accessinfluence of the Dark Triad on various aspects of life – a review
Introduction: The Dark Triad is a construct devised by Paulhus and Williams in 2002. It comprises of three personality disorders: Narcissism, Machiavellianism and psychopathy, that are believed to be debilitating both to people exhibiting these traits and their social environment. Aim of the Study: The aim of the study was to collect and analyse current literature regarding the Dark Triad and the influence of its components on different areas of functioning. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, with the primary focus on literature from the past 5 years. These databases were searched using “the Dark Triad” and its components names as entries to gather articles. Additionally, references from selected articles were included in the analysis. Results: Our article showed that the components of the Dark Triad influence many areas of functioning, although this influence is not always negative. Having all the traits of the Dark Triad is more likely to induce immoral behaviour than having the individual traits in isolation. Thus, further research of the Dark Triad is needed, especially regarding different facets of its components. Devising more in-depth questionnaires that would cover all sub-divisions of the Dark Triad components would largely bolster the research in this field.
- Open Access
- 8 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 52273
Probiotics - should pediatricians and neonatologists use them? A literature review
In recent years, interest in probiotics in publications has been steadily increasing. This is associated with the discovery of the relationship between disruptions in the gut microbiome and dysfunction of the immune system, and consequently, the development of various diseases and allergies. The composition of the natural gut microbiota in newborns can undergo changes, and as a result, we can influence it both prenatally and postnatally. According to available research, factors influencing it include the timing and method of delivery, maternal antibiotic use during pregnancy and breastfeeding, as well as antibiotic use in newborns after birth, and the method of feeding the child. It is suspected that disturbances in the composition of gut microbiota from the earliest stages of life contribute to the development of disorders such as functional gastrointestinal disorders (diarrhea, constipation, irritable bowel syndrome), inflammatory bowel diseases, allergies, atopic dermatitis, neurodevelopmental disorders (autism spectrum disorders), and increased risk of obesity in later years of the child's life. When significant dysbiosis occurs, stimulating the growth of protective and nutritive autochthonous bacteria on the intestinal epithelium is difficult to achieve in any other way than using appropriately selected probiotic strains. However, it is important to remember to choose probiotics with a well-researched quantitative and qualitative composition, and to select them depending on the underlying disease, as well as the age and other conditions of the patient.
- 8 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 52273
Open AccessProbiotics - should pediatricians and neonatologists use them? A literature review
In recent years, interest in probiotics in publications has been steadily increasing. This is associated with the discovery of the relationship between disruptions in the gut microbiome and dysfunction of the immune system, and consequently, the development of various diseases and allergies. The composition of the natural gut microbiota in newborns can undergo changes, and as a result, we can influence it both prenatally and postnatally. According to available research, factors influencing it include the timing and method of delivery, maternal antibiotic use during pregnancy and breastfeeding, as well as antibiotic use in newborns after birth, and the method of feeding the child. It is suspected that disturbances in the composition of gut microbiota from the earliest stages of life contribute to the development of disorders such as functional gastrointestinal disorders (diarrhea, constipation, irritable bowel syndrome), inflammatory bowel diseases, allergies, atopic dermatitis, neurodevelopmental disorders (autism spectrum disorders), and increased risk of obesity in later years of the child's life. When significant dysbiosis occurs, stimulating the growth of protective and nutritive autochthonous bacteria on the intestinal epithelium is difficult to achieve in any other way than using appropriately selected probiotic strains. However, it is important to remember to choose probiotics with a well-researched quantitative and qualitative composition, and to select them depending on the underlying disease, as well as the age and other conditions of the patient.
- Open Access
- 8 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 52283
Urachal abnormalities in the adult population. Is physical activity involved in clinical manifestation Literature review
Introduction The urachal anomaly is a developmental defect, a remnant of fetal life consisting of a patent connection between the dome of the urinary bladder and the umbilicus. It can take various forms. Most commonly it occurs in males, very rarely in adults. The main symptoms associated with this condition are: foul-smelling discharge from the umbilicus, abdominal pain, hematuria, or recurrent urinary tract infections. Imaging plays a crucial role in the diagnosis of the persistent urachus. Aim of the studyThe aim of the study is to sentize doctors’ attention that patent urachus is the rare but possible diagnosis of acute abdomen pain in adults population and bring the proceedings.Materials and methods: An analysis of papers avaliable on Pubmed and Google Scholar was performed. The following key words: urachal anomalies, adults, abdomen pain, urachal remnants, urachal carcinoma were used.Results:Lately, thanks to modern precise imaging diagnostics, more valuable studies have been conducted, allowing to characterize residual ureteral remnants, which are most often asymptomatic in population of adults. However the manifestation of symptoms is mostly associated with infection of the mentioned area or a tumor transformation. There are at least two case reports which report that infection of urachal remnants could manifestate after intensive physical activity. It is worth in-depth interviewing. Studies indicate the necessity of surgical removal of persistent urachal anomalies, as they carry the risk of rapid growth and unfavorable prognosis of cancerous spread.
- 8 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 15, 52283
Open AccessUrachal abnormalities in the adult population. Is physical activity involved in clinical manifestation Literature review
Introduction The urachal anomaly is a developmental defect, a remnant of fetal life consisting of a patent connection between the dome of the urinary bladder and the umbilicus. It can take various forms. Most commonly it occurs in males, very rarely in adults. The main symptoms associated with this condition are: foul-smelling discharge from the umbilicus, abdominal pain, hematuria, or recurrent urinary tract infections. Imaging plays a crucial role in the diagnosis of the persistent urachus. Aim of the studyThe aim of the study is to sentize doctors’ attention that patent urachus is the rare but possible diagnosis of acute abdomen pain in adults population and bring the proceedings.Materials and methods: An analysis of papers avaliable on Pubmed and Google Scholar was performed. The following key words: urachal anomalies, adults, abdomen pain, urachal remnants, urachal carcinoma were used.Results:Lately, thanks to modern precise imaging diagnostics, more valuable studies have been conducted, allowing to characterize residual ureteral remnants, which are most often asymptomatic in population of adults. However the manifestation of symptoms is mostly associated with infection of the mentioned area or a tumor transformation. There are at least two case reports which report that infection of urachal remnants could manifestate after intensive physical activity. It is worth in-depth interviewing. Studies indicate the necessity of surgical removal of persistent urachal anomalies, as they carry the risk of rapid growth and unfavorable prognosis of cancerous spread.
- Open Access
- 11 May 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 50812
Role of dietary supplements in the treatment of asthma - a narrative review
Introduction: Asthma is a common inflammatory disease of airway affecting both adults and children. In a large number of cases asthma remains poorly controlled. There is a need to find an additional therapeutic demeanour alleviating symptoms and lowering the risk complications in a long-term. Recently, increasing number of studies has been examining dietary supplements in regards to their anti-inflammatory, immunomodulatory, anti-remodelling properties and their use in asthmatic patients. Aim of the Study: The aim of the study was to collect and analyse current literature regarding influence of different dietary supplements on the course of asthma in both adults and children. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, with the primary focus on literature from the past 5 years. Firstly, potential dietary supplements affecting course of asthma were collected. The names of the substances were juxtaposed with term “Asthma” to gather data regarding their effect on occurrence and control of asthma and potential mechanisms responsible for it. Additionally, references from selected articles were included in the analysis. Results: Dietary supplements show promising results in decreasing asthma symptoms and lowering inflammation of airway. However, our study revealed that in current state of knowledge there is a deficit of studies performed on humans, especially large-scale, prospective studies that assess the efficacy of different doses of dietary supplements. Thus, further research of dietary supplements in asthma is needed, especially large-scale randomised controlled trials.
- 11 May 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 67, 50812
Open AccessRole of dietary supplements in the treatment of asthma - a narrative review
Introduction: Asthma is a common inflammatory disease of airway affecting both adults and children. In a large number of cases asthma remains poorly controlled. There is a need to find an additional therapeutic demeanour alleviating symptoms and lowering the risk complications in a long-term. Recently, increasing number of studies has been examining dietary supplements in regards to their anti-inflammatory, immunomodulatory, anti-remodelling properties and their use in asthmatic patients. Aim of the Study: The aim of the study was to collect and analyse current literature regarding influence of different dietary supplements on the course of asthma in both adults and children. Methods and Materials: Extensive research was conducted using PubMed and Google Scholar, with the primary focus on literature from the past 5 years. Firstly, potential dietary supplements affecting course of asthma were collected. The names of the substances were juxtaposed with term “Asthma” to gather data regarding their effect on occurrence and control of asthma and potential mechanisms responsible for it. Additionally, references from selected articles were included in the analysis. Results: Dietary supplements show promising results in decreasing asthma symptoms and lowering inflammation of airway. However, our study revealed that in current state of knowledge there is a deficit of studies performed on humans, especially large-scale, prospective studies that assess the efficacy of different doses of dietary supplements. Thus, further research of dietary supplements in asthma is needed, especially large-scale randomised controlled trials.